Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
WuXi Biologics announced that it has completed the topping out of the Drug Product (DP) facility at its Singapore CRDMO Hub.
read more
LJI has signed a licensing agreement with Leinco, a developer and manufacturer of recombinant proteins, antibodies, and conjugates.
read more
Oragenics announced the selection of Southern Star Research as its Clinical Research Organization (CRO) for the upcoming Phase IIa clinical trial of ONP-002, the company’s lead drug candidate for concussion.
read more
Fresenius Kabi USA is voluntarily recalling two lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg/50 mL (4 mcg / mL), 50 mL fill in a 50 mL vial.
read more
Tuesday, September 10, 2019
The FDA’s compounding program aims to help protect patients from poor-quality compounded drugs, while preserving access to lawfully-marketed compounded drugs for patients who have a medical need for them.
read more
Aurinia Pharmaceuticals has selected Worldwide Clinical Trials as its Clinical Research Organization (CRO) for the AURORA Phase 3 study of volcosporin for the treatment of active lupus nephritis (LN).
read more
DILIsym Services announced the FDA has renewed its multi-seat license for the company’s flagship quantitative systems toxicology modeling software, DILIsym®.
read more
Tuesday, December 10, 2019
Catalent has completed clinical production of Bridge Therapeutics’ opioid addiction development therapeutic product, BT-219.
read more
Veranova announced the appointment of Thomas Rohrer as Vice President of Bioconjugation. This appointment follows a recently announced investment to establish cGMP bioconjugation capabilities at its Devens, MA site.
read more
Samsung Biologics announced the completion of its acquisition of a manufacturing facility in Rockville, Maryland from GSK, establishing the company’s first manufacturing presence in the United States.
read more
Tuesday, November 14, 2023
ValGenesis, Inc., and Soluciones GXP have partnered to introduce the ValGenesis VLMS product suite alongside Soluciones GXP's immense regulatory expertise across the life sciences sector in Latin America (LATAM).
Uruguay-based Soluciones GXP ...
read more
Tuesday, October 03, 2017
Medicure announced it has sold its interests in Apicore to an arm's length, pharmaceutical company.
read more
IQVIA™, a global provider of advanced analytics, technology solutions, and clinical research services to the life science industry, has been recognized along with the National Basketball Association and partners at Harvard, Columbia and BioReference ...
read more
Tuesday, October 06, 2020
Sterling Pharma Solutions, has announced its acquisition of Alcami’s Germantown, Wisconsin facility in the US.
read more
Tuesday, November 17, 2020
XOMA has earned a milestone payment from Agenus related to Merck’s advancement of MK-4830 into a Phase 2 study in patients with advanced NSCLC.
read more